Literature DB >> 12167230

Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo.

R Bruce Rutherford1, Maria Moalli, Renny T Franceschi, Dian Wang, Keni Gu, Paul H Krebsbach.   

Abstract

Experimental cell or ex vivo gene therapy for localized bone formation typically uses osteoprogenitor cells propagated from periosteum or bone marrow. Both require bone or marrow biopsies to obtain cells. We have demonstrated that implantation of gingival or dermal fibroblasts transduced with BMP ex vivo, using a recombinant adenovirus (AdCMVBMP) attached to porous biodegradable scaffolds, form bone in vivo. Here we show that BMP-7-transduced fibroblasts suspended in injectable thermoset hydrogels form complete ossicles on subcutaneous injection and repair segmental defects in rat femurs. Bone formation was preceded by an intermediate cartilage stage. To determine the fate of the implanted transduced cells, thermoset hydrogel suspensions of ex vivo BMP-7-transduced or nontransduced fibroblasts were placed in diffusion chambers and implanted to allow development in vivo without direct contact with host cells. Only the BMP-transduced fibroblasts formed bone within the diffusion chambers in vivo, revealing that BMP transduction induces osteoblastic conversion of these cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167230     DOI: 10.1089/107632702760184709

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  41 in total

1.  Effects of designed PLLA and 50:50 PLGA scaffold architectures on bone formation in vivo.

Authors:  Eiji Saito; Elly E Liao; Wei-Wen Hu; Paul H Krebsbach; Scott J Hollister
Journal:  J Tissue Eng Regen Med       Date:  2011-12-09       Impact factor: 3.963

Review 2.  Orthopaedic applications of gene therapy.

Authors:  Martin Lind; Cody Bünger
Journal:  Int Orthop       Date:  2005-05-18       Impact factor: 3.075

3.  Expression of growth differentiation factor-5 and bone morphogenic protein-7 in intraocular osseous metaplasia.

Authors:  S Toyran; A Y Lin; D P Edward
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

4.  The periosteum as a cellular source for functional tissue engineering.

Authors:  Emily J Arnsdorf; Luis M Jones; Dennis R Carter; Christopher R Jacobs
Journal:  Tissue Eng Part A       Date:  2009-09       Impact factor: 3.845

Review 5.  Polymeric growth factor delivery strategies for tissue engineering.

Authors:  Ruth R Chen; David J Mooney
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

6.  Evaluation of multifunctional polysaccharide hydrogels with varying stiffness for bone tissue engineering.

Authors:  Vaibhav Pandit; Jonathan M Zuidema; Kathryn N Venuto; James Macione; Guohao Dai; Ryan J Gilbert; Shiva P Kotha
Journal:  Tissue Eng Part A       Date:  2013-07-11       Impact factor: 3.845

7.  Osteochondral tissue regeneration through polymeric delivery of DNA encoding for the SOX trio and RUNX2.

Authors:  Clark J Needham; Sarita R Shah; Rebecca L Dahlin; Lucas A Kinard; Johnny Lam; Brendan M Watson; Steven Lu; F Kurtis Kasper; Antonios G Mikos
Journal:  Acta Biomater       Date:  2014-05-20       Impact factor: 8.947

Review 8.  A perspective: engineering periosteum for structural bone graft healing.

Authors:  Xinping Zhang; Hani A Awad; Regis J O'Keefe; Robert E Guldberg; Edward M Schwarz
Journal:  Clin Orthop Relat Res       Date:  2008-05-29       Impact factor: 4.176

9.  Patterning expression of regenerative growth factors using high intensity focused ultrasound.

Authors:  Christopher G Wilson; Francisco M Martín-Saavedra; Frédéric Padilla; Mario L Fabiilli; Man Zhang; Alexander M Baez; Christopher J Bonkowski; Oliver D Kripfgans; Richard Voellmy; Nuria Vilaboa; J Brian Fowlkes; Renny T Franceschi
Journal:  Tissue Eng Part C Methods       Date:  2014-03-11       Impact factor: 3.056

10.  Connexin 43 as a signaling platform for increasing the volume and spatial distribution of regenerated tissue.

Authors:  Ricardo A Rosselló; Zhuo Wang; Eddy Kizana; Paul H Krebsbach; David H Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.